Health expert urges FDA to take action to reduce BPA exposure
US action to reduce BPA exposures may offer an effective intervention for improving health and reducing the burden of some of the most consequential human health problems. – Researchers found a significant relationship between urine concentrations of the environmental estrogen bisphenol A (BPA) and cardiovascular disease, type 2 diabetes and liver-enzyme abnormalities.